Warrington Local Business
Tuesday Mar 17 | via Business Journal
Discovery Labs is shifting its focus to its experimental Aerosurf aerosolized surfactant product for respiratory distress syndrome in premature infants. Discovery Laboratories , after spending eight years and million of dollars battling to get its synthetic surfactant drug Surfaxin approved, is shifting its focus to another drug still under development. Comment?
Copyright © 2015 Topix LLC